Anavex Life Sciences Corp. (AVXL)

Anavex Life Sciences Statistics

Total Valuation

AVXL has a market cap or net worth of $811.68 million. The enterprise value is $654.90 million.

Market Cap	811.68M
Enterprise Value	654.90M

Important Dates

The next estimated earnings date is Monday, February 10, 2025, before market open.

Earnings Date	Feb 10, 2025
Ex-Dividend Date	n/a

Share Statistics

AVXL has 84.82 million shares outstanding. The number of shares has increased by 4.61% in one year.

Current Share Class	84.82M
Shares Outstanding	84.82M
Shares Change (YoY)	+4.61%
Shares Change (QoQ)	+0.31%
Owned by Insiders (%)	3.05%
Owned by Institutions (%)	32.27%
Float	82.23M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	6.84
P/TBV Ratio	6.54
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.86

Current Ratio	8.86
Quick Ratio	8.80
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -32.81% and return on invested capital (ROIC) is -24.12%.

Return on Equity (ROE)	-32.81%
Return on Assets (ROA)	-21.81%
Return on Invested Capital (ROIC)	-24.12%
Return on Capital Employed (ROCE)	-42.06%
Revenue Per Employee	n/a
Profits Per Employee	-$1.02M
Employee Count	42
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +37.48% in the last 52 weeks. The beta is 0.70, so AVXL's price volatility has been lower than the market average.

Beta (5Y)	0.70
52-Week Price Change	+37.48%
50-Day Moving Average	9.77
200-Day Moving Average	6.38
Relative Strength Index (RSI)	43.52
Average Volume (20 Days)	1,867,871

Short Selling Information

The latest short interest is 23.40 million, so 27.58% of the outstanding shares have been sold short.

Short Interest	23.40M
Short Previous Month	21.80M
Short % of Shares Out	27.58%
Short % of Float	28.45%
Short Ratio (days to cover)	10.82

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-50.59M
Pretax Income	-41.47M
Net Income	-43.00M
EBITDA	n/a
EBIT	-50.59M
Earnings Per Share (EPS)	-$0.52

Balance Sheet

Cash & Cash Equivalents	132.19M
Total Debt	n/a
Net Cash	132.19M
Net Cash Per Share	$1.56
Equity (Book Value)	120.26M
Book Value Per Share	1.42
Working Capital	120.26M

Cash Flow

Operating Cash Flow	-30.81M
Capital Expenditures	n/a
Free Cash Flow	-30.81M
FCF Per Share	-$0.36

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AVXL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.61%
Shareholder Yield	-4.61%
Earnings Yield	-5.46%
FCF Yield	-3.91%

Analyst Forecast

The average price target for AVXL is $44.00, which is 359.77% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$44.00
Price Target Difference	359.77%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on October 7, 2015. It was a reverse split with a ratio of 0.25:1.

Last Split Date	Oct 7, 2015
Split Type	Reverse
Split Ratio	0.25:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1